Show simple item record

dc.contributor.authorMendi, Ayşegül
dc.contributor.authorKöse, Sevil
dc.contributor.authorUçkan, Duygu
dc.contributor.authorAkca, Gülçin
dc.contributor.authorYilmaz, Derviş
dc.contributor.authorAral, Levent
dc.contributor.authorGültekin, Sibel Elif
dc.contributor.authorEroğlu, Tamer
dc.contributor.authorKiliç, Emine
dc.contributor.authorUçkan, Sina
dc.date.accessioned2020-01-27T09:30:00Z
dc.date.available2020-01-27T09:30:00Z
dc.date.issued2016
dc.identifier.issn1678-7757
dc.identifier.urihttps://doi.org/10.1590/1678-775720150145
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775012/
dc.identifier.urihttp://hdl.handle.net/11655/21869
dc.description.abstractAn increasing body of evidence suggests that the use of probiotic bacteria is a promising intervention approach for the treatment of inflammatory diseases with a polymicrobial etiology. P. gingivalis has been noted to have a different way of interacting with the innate immune response of the host compared to other pathogenic bacteria, which is a recognized feature that inhibits CXCL8 expression.tr_TR
dc.language.isoentr_TR
dc.publisherScientific Electronic Library Onlinetr_TR
dc.relation.isversionof10.1590/1678-775720150145tr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.subjectCXCL8 chemokinetr_TR
dc.subjectStromatr_TR
dc.subjectPeriodontitistr_TR
dc.subjectProbioticstr_TR
dc.subjectReceptortr_TR
dc.subject.lcshTıptr_TR
dc.titleLactobacillus Rhamnosus Could Inhibit Porphyromonas Gingivalis Derived Cxcl8 Attenuationtr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalJournal of Applied Oral Sciencetr_TR
dc.contributor.departmentÇocuk Sağlığı ve Hastalıklarıtr_TR
dc.identifier.volume24tr_TR
dc.identifier.issue1tr_TR
dc.identifier.startpage67tr_TR
dc.identifier.endpage75tr_TR
dc.indexingWoStr_TR
dc.indexingScopustr_TR
dc.indexingPubMedtr_TR
dc.fundingYoktr_TR


Files in this item

This item appears in the following Collection(s)

Show simple item record